Hugh Gannon

Company: KSQ Therapeutics, Inc.

Job title: Associate Director

Seminars:

RNP Control Strategy for CRISPR-Edited TIL Manufacturing 11:30 am

Regulatory expectations for RNP control Analytics for RNP characterization Implementation of RNP control strategy for clinical manufacture to improve gene editing efficiency and to minimize off-target editingRead more

day: Conference Day One